Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Amgen Inc. (AMGN)

« Back to company index

AMGN Chatter Timeline

Stock Ticker for AMGN

Most Active Tweeters for AMGN

UserTweets
@PortfolioBuzz 21
@iamtito_ 11
@optioncharts 9
@Gambiste1 9
@Tickeron 8

Recent Tweets for AMGN

DonnaYoungDC @DonnaYoungDC
ICYMI: Amgen, Lilly, Merck sue HHS over drug price disclosure requirement for TV ads https://t.co/Hypf1QbRnm $AMGN… https://t.co/GK0Im2D1vl
June 17th 2019, 10:06pm
BenAltitude @BenAltitude
@Tr3ndyJon $AMGN as well. Only bottom feeding I ain’t looking to do is with $AGN, too damn ugly.
June 17th 2019, 8:06pm
PortfolioBuzz @PortfolioBuzz
Follow #Nasdaq 100 traders & track their tweets under one watchlist $AMGN $QCOM https://t.co/aT2aUz8Ka2 https://t.co/SRmTErR039
June 17th 2019, 8:06pm
HyllandCapital @HyllandCapital
From an interview with George Rathmann, co-founder and CEO of Amgen $AMGN. How to manage people and projects: (par… https://t.co/ki5jyL3XVN
June 17th 2019, 7:06pm
iamtito_ @iamtito_
$AMGN - Annual Report of Employee Stock Plans (11-k) https://t.co/FRAwhS3dTs
June 17th 2019, 5:06pm
PortfolioBuzz @PortfolioBuzz
Follow #Nasdaq 100 traders & track their tweets under one watchlist $AMGN $QCOM https://t.co/aT2aUz8Ka2 https://t.co/x7leEt4SnJ
June 17th 2019, 2:06pm
daytradersetups @daytradersetups
$AMGN Different View Nice Setup Reversal off our Daily ATS Inflections #daytrading with a Reason and a… https://t.co/Mj3clDhKue
June 17th 2019, 10:06am
daytradersetups @daytradersetups
$AMGN I personally missed this one, What a great trade for some of our clients. Nice Setup Reversal off our Daily… https://t.co/FznmBDur8U
June 17th 2019, 10:06am
Briefingcom @Briefingcom
$AMGN: Amgen announces five-year overall survival analysis from single-arm, Phase 2 BLAST study that evaluated... https://t.co/DGYoUCBEoY
June 17th 2019, 8:06am
optioncharts @optioncharts
$AMGN Max Pain is 130.00 for maturity 06/21/2019. #maxpain #options https://t.co/GHseuYsUre https://t.co/T0PRCZgN2l
June 17th 2019, 6:06am
PortfolioBuzz @PortfolioBuzz
Follow #Nasdaq 100 traders & track their tweets under one watchlist $AMGN $QCOM https://t.co/aT2aUz8Ka2 https://t.co/EmPvu33pVA
June 16th 2019, 8:06pm
HottestStockNow @HottestStockNow
$AMGN Reveals BLINCYTO (blinatumomab) Five-Year Overall Survival Data in patients with minimal residual disease (MR… https://t.co/nHieuRbydY
June 16th 2019, 3:06pm
PortfolioBuzz @PortfolioBuzz
Follow #Nasdaq 100 traders & track their tweets under one watchlist $AMGN $QCOM https://t.co/aT2aUz8Ka2 https://t.co/7ObvNukmbU
June 16th 2019, 3:06pm
optioncharts @optioncharts
$AMGN Max Pain=180.00. Maturity=06/21/2019. #maxpain #options https://t.co/GHseuYsUre https://t.co/K8KuL7Q8Bt
June 16th 2019, 2:06pm
Gambiste1 @Gambiste1
RT @DataTrials: $AMGN Early Phase 1 Biomarker Study of the Antitumoral Activity of Denosumab in the Pre- Operative Setting of Early Breast…
June 16th 2019, 1:06pm
Gambiste1 @Gambiste1
RT @DataTrials: $AMGN Phase 3 Safety, Tolerability & Efficacy on LDL-C of Evolocumab in Subjects With HIV & Hyperlipidemia/Mixed Dyslipidem…
June 16th 2019, 1:06pm
Gambiste1 @Gambiste1
RT @DataTrials: $AMGN Phase 3 Study to Assess if ABP798 is Safe & Effective in Treating Non Hodgkin Lymphoma Compared to Rituximab… Estimat…
June 16th 2019, 1:06pm
Gambiste1 @Gambiste1
RT @DataTrials: $AMGN Phase 1|Phase 2 Study of Oprozomib and Dexamethasone, in Combination With Lenalidomide or Oral Cyclophosphamide in Pa…
June 16th 2019, 1:06pm
DataTrials @DataTrials
$AMGN Early Phase 1 Biomarker Study of the Antitumoral Activity of Denosumab in the Pre- Operative Setting of Early… https://t.co/LEsqR0pWqq
June 16th 2019, 11:06am
DataTrials @DataTrials
$AMGN Phase 1|Phase 2 Study of Oprozomib and Dexamethasone, in Combination With Lenalidomide or Oral Cyclophosphami… https://t.co/iw1jk0gdqu
June 16th 2019, 11:06am
DataTrials @DataTrials
$AMGN Phase 3 Study to Assess if ABP798 is Safe & Effective in Treating Non Hodgkin Lymphoma Compared to Rituximab…… https://t.co/RHcQm1HQm3
June 16th 2019, 11:06am
DataTrials @DataTrials
$AMGN Phase 3 Safety, Tolerability & Efficacy on LDL-C of Evolocumab in Subjects With HIV & Hyperlipidemia/Mixed Dy… https://t.co/XJkDxlyLWx
June 16th 2019, 11:06am
PortfolioBuzz @PortfolioBuzz
Follow #Nasdaq 100 traders & track their tweets under one watchlist $AMGN $QCOM https://t.co/aT2aUyR8Ls https://t.co/oelXuvpCOz
June 16th 2019, 8:06am
StephenPHall3 @StephenPHall3
RT @iamtito_: $AMGN - Amgen Announces BLINCYTO® (blinatumomab) Five-Year Overall Survival Data At EHA 2019 https://t.co/6iJMNNfKbl
June 16th 2019, 8:06am
1MinuteStock @1MinuteStock
Btw, Estimated #Earnings Per Share for $AMGN is $3.09 it's 1.75% of the current price https://t.co/IfKOfHY5Sq
June 16th 2019, 3:06am
Allstocknews @Allstocknews
$AMGN Amgen Announces BLINCYTO® (blinatumomab) Five-Year Overall Survival Data At EHA 2019 From our Stock News Alerts App
June 16th 2019, 2:06am
iamtito_ @iamtito_
$AMGN - Amgen Announces BLINCYTO® (blinatumomab) Five-Year Overall Survival Data At EHA 2019 https://t.co/6iJMNNfKbl
June 16th 2019, 2:06am
ttraderstewie @ttraderstewie
A nice $2.50 move lower in $AMGN out of that BEAR FLAG highlighted two hours ago... https://t.co/YuHrIKKces
June 15th 2019, 7:06pm
ttraderstewie @ttraderstewie
$AMGN .... a bear flag pattern starting to emerge in this one. https://t.co/tENTKUIfCG
June 15th 2019, 7:06pm
7StarMike @7StarMike
$AMGN Next week has some put action, sweeps on and above the ask. https://t.co/mBtjOQgWrB
June 15th 2019, 12:06pm
DavideTavazza @DavideTavazza
$AMGN : sold cash secured puts https://t.co/r1qx66blQz . Available to own it if assigned https://t.co/r1qx66blQz
June 15th 2019, 10:06am
ThisLincolnian @ThisLincolnian
Amgen $AMGN Rating Increased to Hold at BidaskClub https://t.co/kUUkiJDUtM
June 15th 2019, 6:06am
PortfolioBuzz @PortfolioBuzz
Follow #Nasdaq 100 traders & track their tweets under one watchlist $AMGN $QCOM https://t.co/aT2aUz8Ka2 https://t.co/8WbyP8Tdor
June 15th 2019, 3:06am
iamtito_ @iamtito_
$AMGN - Drug Firms Sue Over Ad Rule -- WSJ https://t.co/BCQdCtXDCY
June 15th 2019, 3:06am
iamtito_ @iamtito_
$AMGN - Drugmakers Sue to Block Federal Rule Requiring Drug Prices in TV Ads https://t.co/LXPHgNjA5Y
June 14th 2019, 6:06pm
ZacharyBrennan @ZacharyBrennan
$AMGN suit: the CMS rule could "cause many patients to conclude—incorrectly—that it is not worth asking their drs.… https://t.co/zJQ5ERveLo
June 14th 2019, 3:06pm
finzine @finzine
$LLY $AMGN Drugmakers Sue Trump Administration to Halt Prices-in-Ads Rule via https://t.co/dU2ohMsCEH
June 14th 2019, 3:06pm
optioncharts @optioncharts
$AMGN Max Pain is 180.00 for maturity 06/21/2019. #maxpain #options https://t.co/GHseuYsUre https://t.co/KKwR4mDsn7
June 14th 2019, 1:06pm
newswithvalue @newswithvalue
$AMGN $AGN: The Daily Biotech Pulse: Hematology And Rheumatology …: https://t.co/sF4T5LxoAF
June 14th 2019, 9:06am
PortfolioBuzz @PortfolioBuzz
Follow #Nasdaq 100 traders & track their tweets under one watchlist $AMGN $QCOM https://t.co/aT2aUz8Ka2 https://t.co/rSZ010P938
June 14th 2019, 9:06am
TheMarketsDaily @TheMarketsDaily
Amgen $AMGN Rating Increased to Hold at BidaskClub https://t.co/c165JIVRrE
June 14th 2019, 9:06am
Briefingcom @Briefingcom
$AMGN: Amgen & Allergan (AGN) confirm FDA approval for KANJINTI (trastuzumab-anns) for all approved indications of.… https://t.co/R6ogvnDkKw
June 14th 2019, 8:06am
PortfolioBuzz @PortfolioBuzz
Follow #Nasdaq 100 traders & track their tweets under one watchlist $AMGN $QCOM https://t.co/aT2aUz8Ka2 https://t.co/GLqlyJOClm
June 14th 2019, 3:06am
OptionsMaxPain @OptionsMaxPain
#Options #maxpain chart for $AMGN. Free options app https://t.co/wPNDm22czd https://t.co/SV7WJ78G3h
June 13th 2019, 11:06pm
Ro_Patel @Ro_Patel
$AMGN & $AGN announce that the US FDA has approved KANJINTI (trastuzumab-anns) for all approved indications of the… https://t.co/Skekb6s0Eq
June 13th 2019, 10:06pm
OptionsProOI @OptionsProOI
$AMGN #Options OI chart. Free stocks app https://t.co/hgyHiwuLNm https://t.co/pvtjo3T89k
June 13th 2019, 10:06pm
1MinuteStock @1MinuteStock
Explore #fundamental numbers and pros and cons for $AMGN https://t.co/olJdqsNFGs
June 13th 2019, 10:06pm
RandiMHernandez @RandiMHernandez
RT @jonathanrockoff: [email protected]_FDA approves a biosimilar version of cancer therapy Herceptin from $AGN and $AMGN called Kanjinti, companies say:…
June 13th 2019, 9:06pm
jonathanrockoff @jonathanrockoff
[email protected]_FDA approves a biosimilar version of cancer therapy Herceptin from $AGN and $AMGN called Kanjinti, companies s… https://t.co/gZJ7cF0S8j
June 13th 2019, 7:06pm
Allstocknews @Allstocknews
$AMGN FDA Approves Amgen And Allergan's KANJINTITM (trastuzumab-anns), A Biosimilar To Herceptin® (trastuzuma From our Stock News Alerts App
June 13th 2019, 7:06pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.